Navigation Links
ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
Date:11/12/2008

ot improved. Twenty-four (24) subjects have been followed for greater than one year.

Four hundred and forty seven (447) acute attacks were treated in 82 subjects who had at least one attack. The primary locations of treated attacks were extremities (68); facial (48); gastrointestinal (272); genitourinary (9); and laryngeal (50). According to additional study findings, the median time to improvement was 30 minutes in the 447 attacks that occurred, and 93.4 percent of patients reported improvement in symptoms within 4 hours, regardless of how many times they had previously received Cinryze. None of the subjects in this study treated for laryngeal attacks required hospitalization or intubation, and no serious adverse reactions were considered related to Cinryze administration.

New Data Support Need to Improve Screening for HAE

Despite the potential severity of HAE-related attacks, many patients experience significant delays in receiving an accurate diagnosis of HAE, according to recent survey findings that were also presented at the ACAAI Annual Meeting.

HAE patients from the US, UK, France, Germany, and the Netherlands were invited by their local HAE organization to participate in an online, anonymous online survey. The surveys sought to determine patients' family history of HAE, observe the flow of patients through the healthcare system, and identify differences in medical care. Three hundred and thirteen (313) participants, with an average age of 37 years, completed the questionnaire.

Results from this survey were presented in an abstract entitled "Shortcomings in the diagnosis of hereditary angioedema: Are we adequately screening family members of affected patients?" These results indicated that 65 percent of patients were initially misdiagnosed, which resulted in an unnecessary surgical procedure in more than 20 percent of patients. The average time to diagnosis was 8.3 years after initial presentation of symptoms, and patients a
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
2. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
3. ViroPharma Announces Discontinuation of HCV-796 Development
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. ViroPharma to Present at the Natixis Bleichroeder Conference
7. ViroPharma to Present at Three Upcoming Healthcare Conferences
8. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
9. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
10. Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
11. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014 Echo Therapeutics, Inc. (NASDAQ: ... on skin permeation, continuous glucose monitoring and associated ... has been appointed Chief Executive Officer effective ... 20 years of experience in the medical device, ... served as Vice President, Business Development, Otsuka Pharmaceuticals as ...
(Date:12/24/2014)... -- ResMed (NYSE: RMD ) today announced its ... device manufacturer BMC Medical Co., Ltd. The ... below infringe ResMed,s patents, and entered an order prohibiting BMC ... the United States : , iVolve nasal ... nasal pillows mask , iVolve full face mask ...
(Date:12/24/2014)... 23, 2014   Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today announced ... the Marketing Authorization Application (MAA) for sebelipase alfa ... company,s request for accelerated assessment, which has the ... The MAA, and the Biologics ...
Breaking Medicine Technology:Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3
... ST. PAUL, Minn., Oct. 10, 2011 Prime ... met high standards of pharmacy cost transparency, earning ... certification from the HR Policy Association. This is ... certification. TIPPS certification is given annually ...
... 2011 Cyberonics, Inc. (NASDAQ: CYBX ), ... and management of epilepsy, today announced the resignation of ... Officer, due to personal reasons.  Mr. Reinstein,s resignation is ... current fiscal year.  Until that time, he will assist ...
Cached Medicine Technology:Prime Therapeutics Demonstrates Willingness to Show Actual Pharmacy Costs 2Cyberonics Announces Resignation of James A. Reinstein, Senior Vice President & Chief Commercial Officer 2Cyberonics Announces Resignation of James A. Reinstein, Senior Vice President & Chief Commercial Officer 3
(Date:12/25/2014)... 2014 Recently, Dylan Queen, a famous ... released its collection of discounted prom dresses, most of ... senior spokesman of the company, the promotion is valid ... is to expand the UK market. , The prom ... colors, lengths, and styles: A-line strapless, empire strapless chiffon, ...
(Date:12/25/2014)... Helen Harris’ RP (Retinitis Pigmentosa) International ... after an 8 year battle with breast cancer. ... in her home in Woodland Hills California after an ... , As the founder and volunteer President ... and championed many of today's greatest breakthroughs in restoring ...
(Date:12/25/2014)... risk of burns from fires and cooking accidents increases ... cautious, an expert says. "Between Thanksgiving and New ... coming in with burns," said Dr. Steven Sandoval, medical ... of Stony Brook University Hospital in New York. ... not careful, could quickly turn tragic," Sandoval said in ...
(Date:12/25/2014)... 25, 2014 AngelWeddingDress.com tries its best ... online realm. Today, the business has introduced its new ... prom dress promotion. , The new prom outfits are ... every dress lover. They are specially designed for 2015. ... dresses should visit its website before Jan. 26, ...
(Date:12/25/2014)... Residents at Abernethy Laurels ... their generous spirit by providing holiday gifts to ... Network- Grandparents Raising Grandchildren program. , Following a ... largest Christmas tree on the campus of the ... of the Abernethy Village Association (AVA). Each holiday ...
Breaking Medicine News(10 mins):Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Don't Let Burns Mar Your Holidays 2Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:Retirement Community Residents Make Impact During Holiday Season 2
... 8 Three in ten California households lack enough income ... released today by United Ways of California. The report ... living in California, specific to each county, for housing, food ... child care and taxes. , The complete report, ...
... 8 What careers are in demand? Job prospects for ... grow much faster than average through the year 2014. In ... fastest growing occupations during this time period! Population growth and ... In addition, as dentists, workloads increase, they are expected to ...
... , PORTLAND, Ore., Dec. 8 ... disruption and carcinogens. , It sounds crazy, but well-intentioned shoppers do it ... than ever about things like the food we eat, the paint we use ... are still at substantial risk from the cosmetic beauty products we use on ...
... Registration is open for the 2010 AIUM Annual Convention ... the United States dedicated to all disciplines of medical ... Diego, California. The 2010 Annual Convention focuses on emerging ... scientists, and manufacturers as ultrasound continues to advance and ...
... has identified a potential personalized treatment target for the most ... issue of Cancer Cell , the research team describes ... with any type of cancer was overexpressed in papillary ... They also found evidence suggesting possible mechanisms by which MAGP2 ...
... oxygen treatment , TUESDAY, Dec. 8 (HealthDay News) ... for cluster headaches, British researchers have found. , People ... per day in bouts that last for weeks or ... sumatriptan, but frequent use of the drug isn,t recommended ...
Cached Medicine News:Health News:New Report Finds That Three in Ten California Households Cannot Afford Basic Needs 2Health News:2010 Will Be a Great Year for a Change! Start a New Career Now! 2Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 2Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 3Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 4Health News:AIUM gears up for 2010 Annual Convention in San Diego, California 2Health News:Possible ovarian cancer treatment target identified 2Health News:Oxygen Therapy May Relieve Cluster Headache Pain 2
... Independent controls for Digital Thermostat and Digital ... steel. , Interiorwhite anodized aluminum with ... Oversized refrigeration (134A). , Temperature range ... self-closing doors. , Foamed-in-place polyurethane high ...
... CryoStorage System from Taylor Wharton offers ... from -100C to -196C combined with ... easy accessibility to stroed product, and ... the larger systems, the unique Temperature ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTP/1Q-PAL chairs are recommended for the ... room, static control, health care and ...
Medicine Products: